AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUL 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Vaccine researchers in the United States say that a mixture of systemic and mucosal immunization may offer improved protection against HIV infection.
"Although most HIV-1 infections worldwide result from heterosexual transmission, most vaccine candidates have focused on induction of systemic immunity and protection," explained Zandrea Ambrose and colleagues at the University of Washington in Seattle, Tulane University in New Orleans, Duke University in Durham, North Carolina, and Therion Biologics in Cambridge, Massachusetts.
A vaccine regimen combining systemic priming and mucosal boosting produced effective mucosal protection against vaginal infection in animals, Ambrose and coauthors found.
The researchers compared cellular and humoral immune responses in two groups of macaques primed systemically with a recombinant vaccinia virus-based vaccine. The treatment group received a mucosal boost with an inactivated form of the highly virulent simian-HIV hybrid SHIV89.6 plus adjuvant, they said, while control animals received only adjuvanted protein boosts.
Virus-specific T-cell activity was only seen ...